| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2017-03-20 | Mallinckrodt's intrathecal therapy business (UK) | Piramal (India) | $203 million | |
| 2017-03-17 | Threshold Pharmaceuticals (USA - CA) | Molecular Templates (USA - TX) | Cancer - Oncology | |
| 2017-03-16 | PCT, a Caladrius Company (USA - CA) | Hitachi Chemical Co. America (USA - CA) | $75 million in cash and $5 million revenue-based milestone | Technology - Services Production - Manufacturing |
| 2017-03-01 | CoLucid Pharmaceuticals (USA - IN) | Eli Lilly (USA - IN) | $960 million | CNS diseases - Neurological diseases |
| 2017-02-28 | Genticel (France) | Genkyotex (Switzerland) | € 30 million | Cancer-Oncology Infectious diseases |
| 2017-02-16 | Ariad Pharmaceuticals (USA - MA) | Takeda Pharmaceutical (Japan) | $5.2 billion | Cancer - Oncology |
| 2017-02-13 | Zeltiq Aesthetics (USA - CA) | Allergan (Ireland) | $2.475 billion | Aesthetic medicine |
| 2017-02-13 | Signal Therapeutics (USA - IIO) | Miragen Therapeutics (USA - CA) | ||
| 2017-01-31 | Akkadeas Pharma (Italy) | Ipsen (France) | Gastrointestinal diseases | |
| 2017-01-27 | Mallinckrodt's nuclear imaging business (UK) | IBA Molecular (Belgium) | $690 million | |
| 2017-01-26 | Delinia (USA - MA) | Celgene (USA - NJ) | up to $ 775 million | Autoimmune diseases |
| 2017-01-25 | Xpand Biotechnology (The Netherlands) | Kuros Biosciences (Switzerland) | ||
| 2017-01-24 | GenVec (USA - MD) | Intrexon (USA - MD) | Gene therapy |
|
| 2017-01-19 | Martindale Pharma (UK) | Ethypharm (France) | ||
| 2017-01-18 | Disposable-Lab (France) | Amatsigroup (France) | ||
| 2017-01-09 | Lysosomal Therapeutics (USA - MA) | Allergan (Ireland) | CNS diseases - Neurodegenerative diseases | |
| 2017-01-04 | peptides business and operations of Lonza in Braine-l’Alleud (Belgium) | PolyPeptide Laboratories (Denmark) | undisclosed | Manufacturing - Bioproduction |
| 2016-12-29 | Villapharma (Spain) | Eurofins Scientific (Luxembourg) | ||
| 2016-12-20 | LifeCell Corporation (USA - NJ) | Allergan (Ireland) | $2.9 Billion | Regenerative medicine |
| 2016-12-16 | Ziarco Group (USA) | Novartis (Switzerland) | undisclosed | Dermatological diseases |
